ReNAgade Therapeutics

0 followers


ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease. RNA delivery systems with a comprehensive RNA platform that allows for an all-RNA system for coding, editing, and gene insertion to produce new medications.

Industries

+2

Headquarters

Stage

Employees

Links

Org chart

Dong Wei
Head of Bioanalysis
Joel Yeshman
Senior Director Finance
Peter Smith, Ph.D.
Chief Scientific Officer
Scott Barros
VP, Toxicology & Pathology
Stevelyn Desire aPHR®
Senior Associate People Experience